<img alt="" src="https://secure.visionary-data-intuition.com/781568.png" style="display:none;">
Mask Group 18@2x

SAEfe - A quantum leap in safety reporting

NWEH are proud to announce the launch of our new Serious Adverse Event (SAE) reporting functionality, SAEfe. Powered by ConneXon, is a revolutionary advancement in clinical trial SAE reporting that promises to save up to 70% of the overall costs associated with reporting adverse events.

SAEfe allows the user to complete the SAE report without transcription with data extracted directly from the participant’s electronic health record (EHR). This reduces transcription errors and improves accuracy. Other relevant medical conditions and information can easily be selected and added to the report.

With the integration of SAEfe into the ConneXon platform, NWEH continues to set the standard for clinical trial efficiency and participant safety. Jonathan Wogel, CEO of NWEH said "The launch of SAEfe marks a significant milestone in our mission to bring new medicines to market faster. The use of anonymised EHR data in clinical trials is nothing new anymore. What is new, is using the EHR data to auto populate the SAE report saving our customers a significant amount of time and money. Through close collaboration with our customers we can develop significant advancements, like SAEfe, that streamline the clinical trial processes adding value where needed.”

Using SAEfe, completed SAE forms are securely delivered to the sponsor using the industry standard ICH E2B ICSR format, making reconciliation a quick and easy process. This significant reduction in administrative burden enables researchers to focus on the wellbeing of the participants and overall trial delivery. This milestone underscores NWEH’s commitment to improving clinical trial efficiency and participant safety, setting a new industry standard.

SAEfe marks a significant advancement in clinical trial safety reporting through technical innovation.

Discover more here

Add your comment